The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis
- PMID: 28921803
- DOI: 10.1111/liv.13589
The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis
Abstract
Patients with cirrhosis and portal hypertension often develop complications from a variety of organ systems leading to a multiple organ failure. The combination of liver failure and portal hypertension results in a hyperdynamic circulatory state partly owing to simultaneous splanchnic and peripheral arterial vasodilatation. Increases in circulatory vasodilators are believed to be due to portosystemic shunting and bacterial translocation leading to redistribution of the blood volume with central hypovolemia. Portal hypertension per se and increased splanchnic blood flow are mainly responsible for the development and perpetuation of the hyperdynamic circulation and the associated changes in cardiovascular function with development of cirrhotic cardiomyopathy, autonomic dysfunction and renal dysfunction as part of a cardiorenal syndrome. Several of the cardiovascular changes are reversible after liver transplantation and point to the pathophysiological significance of portal hypertension. In this paper, we aimed to review current knowledge on the pathophysiology of arterial vasodilatation and the hyperdynamic circulation in cirrhosis.
Keywords: cardiac dysfunction; liver failure; multi-organ syndrome; portal hypertension.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.World J Gastroenterol. 2014 Mar 14;20(10):2555-63. doi: 10.3748/wjg.v20.i10.2555. World J Gastroenterol. 2014. PMID: 24627591 Free PMC article. Review.
-
Splanchnic and systemic vasodilatation: the patient.J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S266-71. doi: 10.1097/MCG.0b013e3181576d1a. J Clin Gastroenterol. 2007. PMID: 17975476 Review.
-
[Hyperdynamic circulation in patients with liver cirrhosis and portal hypertension].Korean J Gastroenterol. 2009 Sep;54(3):143-8. doi: 10.4166/kjg.2009.54.3.143. Korean J Gastroenterol. 2009. PMID: 19844149 Review. Korean.
-
[Physiopathologic basis of medical therapy of portal hypertension in cirrhosis].Ann Ital Med Int. 1996 Oct;11 Suppl 2:39S-47S. Ann Ital Med Int. 1996. PMID: 9004819 Review. Italian.
-
Pathophysiology of portal hypertension.Clin Liver Dis. 2014 May;18(2):281-91. doi: 10.1016/j.cld.2013.12.001. Epub 2014 Feb 25. Clin Liver Dis. 2014. PMID: 24679494 Free PMC article. Review.
Cited by
-
Medical Therapy for Heart Failure in Adult Congenital Heart Disease Patients.Struct Heart. 2024 Apr 10;8(4):100297. doi: 10.1016/j.shj.2024.100297. eCollection 2024 Jul. Struct Heart. 2024. PMID: 39100588 Free PMC article. Review.
-
Cardiovascular risk assessment and predictors of cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.World J Gastroenterol. 2025 Jul 21;31(27):107740. doi: 10.3748/wjg.v31.i27.107740. World J Gastroenterol. 2025. PMID: 40741106 Free PMC article.
-
Evaluation of Electrocardiogram Parameters and Heart Rate Variability During Blood Pressure Elevation by Phenylephrine in Cirrhotic Rats.Cardiovasc Toxicol. 2024 Mar;24(3):321-334. doi: 10.1007/s12012-024-09839-4. Epub 2024 Feb 26. Cardiovasc Toxicol. 2024. PMID: 38409566
-
Acute-on-Chronic Liver Failure: Pathophysiological Mechanisms and Management.Front Med (Lausanne). 2021 Nov 8;8:752875. doi: 10.3389/fmed.2021.752875. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34820395 Free PMC article. Review.
-
Acute kidney injury: prediction, prognostication and optimisation for liver transplant.Hepatol Int. 2020 Mar;14(2):167-179. doi: 10.1007/s12072-020-10018-0. Epub 2020 Mar 3. Hepatol Int. 2020. PMID: 32128705 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical